The largest database of trusted experimental protocols

Polyclonal rabbit anti human vwf

Manufactured by Agilent Technologies
Sourced in Denmark

Polyclonal rabbit anti-human VWF is a laboratory reagent that detects and binds to human von Willebrand factor (VWF), a protein involved in blood clotting. This product is intended for research use only.

Automatically generated - may contain errors

8 protocols using polyclonal rabbit anti human vwf

1

Quantification of Pulmonary Vascular Remodeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pulmonary vascular remodeling was evaluated as previously described [19 (link)]. Briefly, lung sections were stained with polyclonal rabbit antihuman VWF (Dako), mouse anti α-Smooth Muscle Actin (SMA) (Sigma, St Louis, MO), a marker of smooth muscle in the medial wall of vessels, and DAPI (Vector Laboratories). Five randomly selected non-overlapping parenchymal fields were evaluated from lung sections of each animal. The blood vessels (20–50 μm in diameter) in each high-power field were counted by a blinded observer and the degree of muscularization assessed at that time [31 (link)]. Medial wall thickness was measured in 20 randomly selected arterioles (20–50 μm in diameter) at 40X magnification as previously described [32 (link)]. Briefly, the thickness of the medial layer of the arteriole was identified using SMA fluorescence and measured at its thickest portion. The average diameter of the arteriole was also obtained. The medial wall thickness index was calculated as 2 X measured thickness of the medial layer / average diameter of the vessel X 100%.
+ Open protocol
+ Expand
2

Quantifying VWF and ADAMTS13 activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The VWF concentration in patient sera was measured by sandwich ELISA as described previously (13 (link)), using polyclonal rabbit anti-human VWF as a capture antibody and HRP-conjugated polyclonal rabbit anti-human VWF as a detection antibody (Dako, Troy, MI). ADAMTS13 activity in patient sera was measured using an enzyme-linked assay to evaluate cleavage of a horseradish peroxidase (HRP)-conjugated peptide from the VWF A2 domain as previously described (25 (link)).
+ Open protocol
+ Expand
3

Pulmonary Vascular Remodeling Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pulmonary vascular remodeling was evaluated as previously described.27 (link) Briefly, lung sections were stained with polyclonal rabbit antihuman vWF (1:50; Dako) and mouse anti-α-smooth muscle actin (α-SMA: 1:500, Sigma, St Louis, MO). Five randomly selected non-overlapping parenchymal fields were evaluated from the lung sections of each animal. Blood vessels (20-50 µm in diameter) in each HPF were counted by a blinded observer and the degree of muscularization was assessed.28 (link) Medial wall thickness was measured in 20 randomly selected arterioles (20-50 µm in diameter) at 40× magnification as previously described.28 (link) Briefly, the thickness of the medial layer of the arteriole was calculated using the formula 2× measured thickness of the medial layer/ average diameter of the vessel × 100%.
+ Open protocol
+ Expand
4

VWF Clearance in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
VWF−/− mice on a C57BL/6J background were obtained from the Jackson Laboratory (Sacramento, Ca, USA). All in vivo clearance experiments were performed on 6-8 week-old mice, in accordance with the Health Product Regulatory Authority, Ireland as previously described.19 Mice were infused with 30 nM A1A2A3-VWF or PEGylated variants thereof via tail-vein injection and anesthetised with 2.5% tribromoethanol (0.2 ml per 10 g body weight). Blood was collected via sub-clavicle incision into lithium-heparin coated microtainers. Three to five mice per time point were used. Residual plasma VWF:Ag levels were determined at specific time points up to 24 h by VWF:Ag ELISA, using polyclonal rabbit anti-human VWF (Dako, Denmark). As previous a highly purified A1A2A3-VWF protein was first used to create a standard curve this for this ELISA.19
+ Open protocol
+ Expand
5

Pulmonary Vascular Remodeling Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pulmonary vascular remodeling was evaluated as previously described [36 (link)]. Briefly, lung sections were stained with polyclonal rabbit anti-human vWF (Dako), mouse anti α-smooth muscle actin (SMA,1:500; Sigma, St Louis, MO) and 4′,6-diamidino-2-phenylindole (DAPI, Vector Biolabs, Burlingame, CA). The percentage of peripheral pulmonary vessels (< 50 μm in diameter) stained with α-SMA > 50% of the circumference was determined from ten random images on each lung section and all analyses were performed by a blinded observer.
+ Open protocol
+ Expand
6

Simplagrin Binding to von Willebrand Factor

Check if the same lab product or an alternative is used in the 5 most similar protocols
Polystyrene plates were coated with 100 µL of collagen type III (0.3 µg/mL) or a 2% (w/v) solution of BSA diluted in PBS for two hours at 37°C. After washing twice with PBS to remove unbound protein, residual binding sites were blocked by adding 5 mg/mL denatured BSA overnight at 4°C. After washing 3× with 50 mM Tris HCl, 150 mM NaCl, and 0.05% (v/v), TBS-T, pH 7.4, increasing concentrations of recombinant Simplagrin (ranging from 0.0015 to 1.5 µM) were added to the wells and incubated at 37°C for one hour. Wells were washed again and incubated with 3 nM of vWF factor VIII free (Haematologic Technologies Inc.) in TBS-T supplemented with 2% (w/v) BSA. After one hour at 37°C, wells were washed 3× with TBS-T, and a polyclonal rabbit anti-human vWF (DakoCytomation) was added (1∶500 in TBS-T) and incubated for one hour at 37°C. After three washes with TBS-T, an alkaline phosphatase conjugate anti-rabbit IgG (whole molecule; Sigma) was added (1∶10000) and incubated at 37°C for 45 minutes. Before adding the stabilized p-nitrophenyl phosphate liquid substrate (Sigma), wells were washed 6× with TBS-T. After 30 minutes of substrate conversion, the reaction was stopped with 3 N NaOH and absorbance read at 405 nm using a Thermomax microplate reader (Molecular Devices). Wells coated only with BSA were used as assay blanks. All experiments were performed in triplicate.
+ Open protocol
+ Expand
7

VWF:Ag Quantification by ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
VWF:Ag was determined by enzyme-linked immunosorbent assay (ELISA) using an in-house assay and had a lower limit of quantification (LLOQ) of 4 IU/dL. VWF was captured using polyclonal rabbit antihuman VWF (DAKO, Glostrup, Denmark) coated on microplate wells. polyclonal rabbit antihuman VWF/horseradish peroxidase (HRP) conjugate (DAKO) was added and incubated. After a washing step, bound VWF/HRP conjugate complex was detected using tetramethyl-benzidine reagent. The absorbance was read at 450 nm using a microplate reader. VWF:Ag was calculated relative to a human plasma reference (citrated; Siemens AG, Munich, Germany) calibrated versus the World Health Organization plasma standard.29 (link)
+ Open protocol
+ Expand
8

VWF Localization in Injured Kidney

Check if the same lab product or an alternative is used in the 5 most similar protocols
Localization of VWF within the injured kidney was investigated by immunofluorescence double staining using confocal laser scanning microscopy (Zeiss LSM 710, Zeiss, Germany). After cutting, antigen retrieval and blocking, formalin-fixed paraffin sections were incubated with polyclonal rabbit anti-human VWF (Dako, Copenhagen, Denmark) and monoclonal rat anti-mouse CD42b (GPIb, emfret Analytics, Eibelstadt, Germany), as well as the secondary antibodies Alexa555-conjugated goat anti-rat (Invitrogen, Eugene, Oregon, USA) and FITC-conjugated goat anti-rabbit (BD Pharmingen, USA), as described previously6 ,32 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!